BioAnalytics’ technology is applicable to nearly any immunoassay regardless of the target analyte or detection method. This system has the potential to enhance the speed and simplicity of immunoassays in 96-well plate, microarray, or microfluidic platforms. Previous applications have resulted in a 92% increase in rate as well as a 98% increase in assay precision.

BioAnalytics is presently seeking partnerships with companies developing immunoassays for applications in medical laboratories, academic research, pharmaceutical development, as well as food and water quality control. We welcome inquiries to explore the possibility of collaboration.

For further information, please contact BioAnalytics’ Business Development Group.